We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

East-West Hepatocellular Carcinoma Study Group

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01237132
First Posted: November 9, 2010
Last Update Posted: November 9, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University of Milan
November 8, 2010
November 9, 2010
November 9, 2010
Not Provided
Not Provided
Overall survival of resected patients for HCC
The primary endpoint of the study was the overall survival of patients resected for HCC in any stage of the BCLC classification.
Same as current
No Changes Posted
Disease-free survival of resected patients for HCC
The secondary endpoint was the disease-free survival of patients resected for HCC among the BCLC stages.
Same as current
Not Provided
Not Provided
 
East-West Hepatocellular Carcinoma Study Group
EAST-WEST HEPATOCELLULAR CARCINOMA STUDY GROUP
The current treatment guidelines of hepatocellular carcinoma (HCC) of the American and European Associations for the Study of Liver Disease are based on the Barcelona-Clinic-Liver-Cancer classification (BCLC), which does not recommend surgery in patients with large, multinodular and macrovascular invasive disease. The aim of this study was to investigate the role of hepatic resection in a large retrospective multicentric cohort of patients resected for HCC regardless of the BCLC indications.
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Retrospective
Not Provided
Not Provided
Non-Probability Sample
Patients affected by HCC
Carcinoma, Hepatocellular
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
Not Provided
Not Provided
Not Provided

Inclusion Criteria:

  • clinical diagnosis of hepatocellular carcinoma
  • candidate to liver resection as a curative treatment

Exclusion Criteria:

  • uncertain diagnosis of hepatocellular carcinoma
  • uncertain follow-up data
Sexes Eligible for Study: All
Child, Adult, Senior
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
 
NCT01237132
HCC EWE
No
Not Provided
Not Provided
GUIDO TORZILLI MD, PHD, UNIVERSITY OF MILAN
University of Milan
Not Provided
Not Provided
University of Milan
December 2009